Epac1对垂体腺瘤细胞增殖和细胞周期的影响及分子机制研究

孙炜; 王俊文; 李然; 黄逸民; 张卓; 雷霆

doi:10.11659/jjssx.10E022066

您当前的位置：

首页 >

文章列表页 >

Epac1对垂体腺瘤细胞增殖和细胞周期的影响及分子机制研究

基础研究 | 更新时间：2023-12-13

- Epac1对垂体腺瘤细胞增殖和细胞周期的影响及分子机制研究
- Effects and molecular mechanisms of Epac1 on pituitary adenoma cell proliferation and cell cycle
- 局解手术学杂志 2023年32卷第12期页码：1029-1034
- 作者机构：
  
  华中科技大学同济医学院附属同济医院神经外科，湖北武汉 430030
- 作者简介：
  
  雷霆，E-mail：tlei@tjh.tjmu.edu.cn
- 基金信息：
  
  国家自然科学基金(82173136)
- DOI：10.11659/jjssx.10E022066
  中图分类号： R736.4
- 纸质出版日期：2023-12-25，
  
  收稿日期：2022-10-15，
扫描看全文
孙炜,王俊文,李然等.Epac1对垂体腺瘤细胞增殖和细胞周期的影响及分子机制研究[J].局解手术学杂志,2023,32(12):1029-1034.

SUN Wei,WANG Jun-wen,LI Ran,et al.Effects and molecular mechanisms of Epac1 on pituitary adenoma cell proliferation and cell cycle[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(12):1029-1034.
孙炜,王俊文,李然等.Epac1对垂体腺瘤细胞增殖和细胞周期的影响及分子机制研究[J].局解手术学杂志,2023,32(12):1029-1034. DOI： 10.11659/jjssx.10E022066.

SUN Wei,WANG Jun-wen,LI Ran,et al.Effects and molecular mechanisms of Epac1 on pituitary adenoma cell proliferation and cell cycle[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2023,32(12):1029-1034. DOI： 10.11659/jjssx.10E022066.

摘要

目的

探索垂体生长激素腺瘤细胞增殖的分子机制。

方法

收集12例肢端肥大症患者的功能性生长激素垂体腺瘤（fGH-PA）组织样本。qPCR法测定fGH-PA组织和大鼠RGC-5、MMQ、GH3细胞中cAMP直接激活的交换蛋白1（Epac1） mRNA表达水平。免疫组织化学测定fGH-PA组织中Epac1蛋白表达情况。Western blot测定MMQ、GH3细胞中Epac1蛋白表达情况。在GH3细胞中过表达或敲低Epac1，或敲低cAMP反应元件结合蛋白(CREB)，流式细胞术测定细胞周期变化；CCK-8法测定细胞增殖能力；Western blot测定细胞内p-CREB、CREB、Cyclin D1、CDK2、p21的表达情况。

结果

qPCR和免疫组织化学结果显示，与旁侧正常组织相比，fGH-PA组织中Epac1 mRNA和蛋白表达水平明显增高（

0.05）。qPCR和Western blot结果显示，与RGC-5细胞相比，MMQ和GH3细胞中Epac1 mRNA和蛋白表达水平明显增高（

0.05）。在GH3细胞中过表达Epac1后，与Control组相比，Epac1-OE组G0/G1期和S期细胞占比明显减少（

0.05），G2/M期细胞占比明显增多（

0.05）；细胞增殖能力明显增强（

0.05）；细胞内p-CREB和Cyclin D1的表达水平明显升高（

0.05），CDK2和p21的表达水平明显降低（

0.05），而CREB的表达水平无明显变化（

0.05）。在GH3细胞中敲低Epac1或敲低CREB后，上述所有结果均发生逆转（

0.05）。

结论

垂体生长激素腺瘤细胞中Epac1过表达能够上调细胞内p-CREB的水平，并促进腺瘤细胞通过G1/S期检查点，发生细胞周期检查点失调和大量增殖，但不影响CREB的表达水平。

Abstract

Objective

To explore the molecular mechanism of pituitary growth hormone adenoma cell proliferation.

Methods

Functional growth hormone-secreting pituitary adenoma （fGH-PA） tissue samples were collected from 12 patients with acromegaly. The exchange protein 1 directly activated by cAMP （Epac1） mRNA expression levels in fGH-PA tissues and rat RGC-5，MMQ and GH3 cells were determined by qPCR. The expression levels of Epac1 in fGH-PA tissues were determined by immunohistochemistry. Western blot was used to determine the expression levels of Epac1 in MMQ and GH3 cells. Overexpression or knockdown of Epac1， or knockdown of cAMP response element-binding protein （CREB） in GH3 cells， cell cycle changes were determined by flow cytometry， cell proliferation ability was determined by CCK-8 assay， and the expression levels of p-CREB， CREB， Cyclin D1， CDK2 and p21 in cells were determined by Western blot.

Results

qPCR and immunohistochemistry results showed that the expression levels of Epac1 mRNA and protein in fGH-PA tissues were significantly higher than those in adjacent normal tissues （

0.05）. qPCR and Western blot results showed that compared with RGC-5 cells， the expression levels of Epac1 mRNA and protein in MMQ and GH3 cells were significantly increased （

0.05）. After overexpression of Epac1 in GH3 cells， compared with the Control group， the proportion of cells in G0/G1 phase and S phase in the Epac1-OE group were significantly reduced （

0.05）， and the proportion of cells in G2/M phase were significantly increased （

0.05）； the cell proliferation ability were significantly enhanced （

0.05）； the expression levels of p-CREB and Cyclin D1 in cells were significantly increased （

0.05）， the expression levels of CDK2 and p21 were significantly decreased （

0.05）， while there was no significant change in the expression level of CREB between the two groups （

0.05）. After knockdown of Epac1 or knockdown of CREB in GH3 cells， all of the above results were reversed （

0.05）.

Conclusion

The overexpression of Epac1 in pituitary growth hormone adenoma cells can up-regulate the levels of p-CREB in cells， and promote adenoma cells to pass through G1/S phase checkpoint， resulting in cell cycle checkpoint disorder and massive proliferation， but it does not affect the expression levels of CREB.

关键词

功能性生长激素垂体腺瘤细胞增殖细胞周期G1/S期检查点蛋白Epac1CREB

Keywords

functional growth hormone-secreting pituitary adenomacell proliferationcell cycleG1/S phase checkpoint proteinEpac1CREB

references

Daly AF，Beckers A.The epidemiology of pituitary adenomas［J］.Endocrinol Metab Clin North Am，2020，49（3）：347-355.doi：10.1016/j.ecl.2020.04.002http://dx.doi.org/10.1016/j.ecl.2020.04.002.

赵鹏，刘志远，许可，等.垂体腺瘤神经外科临床路径［J］.中国肿瘤外科杂志，2022，14（1）：16-21.doi：10.3969/j.issn.1674-4136.2022.01.004http://dx.doi.org/10.3969/j.issn.1674-4136.2022.01.004.

朱惠娟，王任直.垂体腺瘤临床诊治进展［J］.协和医学杂志，2020，11（5）：533-536.doi：10.3969/j.issn.1674-9081.2020.05.007http://dx.doi.org/10.3969/j.issn.1674-9081.2020.05.007.

高巍，赵莉红，王玮，等.基于WHO新分类的垂体腺瘤诊断及临床病理分析［J］.首都医科大学学报，2020，41（3）：364-371.doi：10.3969/j.issn.1006-7795.2020.03.009http://dx.doi.org/10.3969/j.issn.1006-7795.2020.03.009.

Ilie MD，Jouanneau E，Raverot G.Aggressive pituitary adenomas and carcinomas［J］.Endocrinol Metab Clin North Am，2020，49（3）：505-515.doi：10.1016/j.ecl.2020.05.008http://dx.doi.org/10.1016/j.ecl.2020.05.008.

Wehbe N，Slika H，Mesmar J，et al.The role of Epac1 in cancer progression［J］.Int J Mol Sci，2020，21（18）：6489.doi：10.3390/ijms21186489http://dx.doi.org/10.3390/ijms21186489.

Wang X，Luo C，Cheng X，et al.Lithium and an Epac1-specific inhibitor ESI-09 synergistically suppress pancreatic cancer cell proliferation and survival［J］.Acta Biochim Biophys Sin （Shanghai），2017，49（7）：573-580.doi：10.1093/abbs/gmx045http://dx.doi.org/10.1093/abbs/gmx045.

Richard SA.Epac12：A new and promising protein for glioma pathogenesis and therapy［J］.Oncol Rev，2020，14（1）：446.doi：10.4081/oncol.2020.446http://dx.doi.org/10.4081/oncol.2020.446.

Jin X，Di X，Wang R，et al.RBM10 inhibits cell proliferation of lung adenocarcinoma via RAP1/AKT/CREB signalling pathway［J］.J Cell Mol Med，2019，23（6）：3897-3904.doi：10.1111/jcmm.14263http://dx.doi.org/10.1111/jcmm.14263.

Chen P，Li M，Hao Q，et al.Targeting the overexpressed CREB inhibits esophageal squamous cell carcinoma cell growth［J］.Oncol Rep，2018，39（3）：1369-1377.doi：10.3892/or.2017.6167http://dx.doi.org/10.3892/or.2017.6167.

Chung JH，Kim DH，Kim YS，et al.Upregulation of p21-activated kinase 1 （PAK1）/CREB axis in squamous non-small cell lung carcinoma［J］.Cell Physiol Biochem，2018，50（1）：304-316.doi：10.1159/000494007http://dx.doi.org/10.1159/000494007.

Yamada T，Amann JM，Fukuda K，et al.Akt kinase-interacting protein 1 signals through creb to drive diffuse malignant mesothelioma［J］.Cancer Res，2018，75（19）：4188-4197.doi：10.1158/0008-5472.CAN-15-0858http://dx.doi.org/10.1158/0008-5472.CAN-15-0858.

Qie S，Diehl JA.Cyclin D1，cancer progression，and opportunities in cancer treatment［J］.J Mol Med （Berl），2016，94（12）：1313-1326.doi：10.1007/s00109-016-1475-3http://dx.doi.org/10.1007/s00109-016-1475-3.

Xiong Y，Wang Y，Li T，et al.A novel function for cyclin D1 as a transcriptional role in oncogenesis and tumor development by ChIP-Seq and RNA-Seq［J］.J Cancer，2021，12（17）：5181-5192.doi：10.7150/jca.52909http://dx.doi.org/10.7150/jca.52909.

Liu L，Zhang H，Shi L，et al.Inhibition of Rac1 activity induces G1/S phase arrest through the GSK3/cyclin D1 pathway in human cancer cells［J］.Oncol Rep，2017，32（4）：1395-1400.doi：10.3892/or.2014.3388http://dx.doi.org/10.3892/or.2014.3388.

Bačević K，Lossaint G，Achour TN，et al.CDK2 strengthens the intra-S checkpoint and counteracts cell cycle exit induced by DNA damage［J］.Sci Rep，2017，7（1）：13429.doi：10.1038/s41598-017-12868-5http://dx.doi.org/10.1038/s41598-017-12868-5.

Liu K，Graves JD，Lee YJ，et al.Cell cycle-dependent switch of TopBP1 functions by CDK2 and AKT［J］.Mol Cell Biol，2020，40（8）：e00599-19.doi：10.1128/MCB.00599-19http://dx.doi.org/10.1128/MCB.00599-19.

Hume S，Grou CP，Lascaux P，et al.The NUCKS1-SKP2-p21/p27 axis controls S phase entry［J］.Nat Commun，2021，12（1）：6959.doi：10.1038/s41467-021-27124-8http://dx.doi.org/10.1038/s41467-021-27124-8.

Wu Y，Wang Y，Liu M，et al.Suv4-20h1 promotes G1 to S phase transition by downregulating p21 WAF1/CIP1 expression in chronic myeloid leukemia K562 cells［J］.Oncol Lett，2018，15（5）：6123-6130.doi：10.3892/ol.2018.8092http://dx.doi.org/10.3892/ol.2018.8092.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

lncRNA MIR4435-2HG靶向miR-376a-3p调控胆管癌细胞生物学行为的机制研究

circDNMT1调节miR-377-3p/PUM1轴对三阴性乳腺癌细胞增殖、凋亡和上皮-间质转化的影响

DCST1-AS1在非小细胞肺癌中的表达及其生物学作用

迷迭香酸通过PI3K/AKT/mTOR信号通路抑制喉癌细胞的增殖和迁移

大豆苷元靶向MMP12发挥抗口腔鳞状细胞癌的作用